Language impairment in progressive supranuclear palsy and corticobasal syndrome

1.

Knibb JA, Xuereb JH, Patterson K, Hodges JR (2006) Clinical and pathological characterization of progressive aphasia. Ann Neurol 59:156–165. https://doi.org/10.1002/ana.20700CrossRefPubMed

2.

Nestor PJ, Graham NL, Fryer TD et al (2003) Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 126:2406–2418. https://doi.org/10.1093/brain/awg240CrossRefPubMed

3.

Cope TE, Sohoglu E, Sedley W et al (2017) Evidence for causal top-down frontal contributions to predictive processes in speech perception. Nat Commun. https://doi.org/10.1038/s41467-017-01958-7CrossRefPubMedPubMedCentral

4.

Josephs KA, Hodges JR, Snowden JS et al (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137–153CrossRef

5.

Hodges JR, Mitchell J, Dawson K et al (2010) Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 133:300–306. https://doi.org/10.1093/brain/awp248CrossRefPubMed

6.

Rabinovici GD, Jagust WJ, Furst AJ et al (2008) Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388–401. https://doi.org/10.1002/ana.21451CrossRefPubMedPubMedCentral

7.

Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359. https://doi.org/10.1001/archneur.1964.00460160003001CrossRefPubMed

8.

Albert ML, Feldman RG, Willis AL (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37:121–130. https://doi.org/10.1136/JNNP.37.2.121CrossRefPubMedPubMedCentral

9.

Bak TH, Crawford LM, Hearn VC et al (2005) Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 11:268–273. https://doi.org/10.1080/13554790590962997CrossRefPubMed

10.

Höglinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864. https://doi.org/10.1002/mds.26987CrossRefPubMedPubMedCentral

11.

Gazzina S, Respondek G, Compta Y et al (2019) Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degeneration. bioRxiv. https://doi.org/10.1101/520510CrossRef

12.

Lang AE, Riley DE, Bergeron C (1994) Cortical-basal ganglionic degeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 877–894

13.

Burrell JR, Hodges JR, Rowe JB (2014) Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29:684–693. https://doi.org/10.1002/mds.25872CrossRefPubMed

14.

Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53:1969–1974. https://doi.org/10.1212/WNL.53.9.1969CrossRefPubMed

15.

Kertesz A, McMonagle P (2010) Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 289:138–143. https://doi.org/10.1016/j.jns.2009.08.036CrossRefPubMed

16.

Mathew R, Bak TH, Hodges JR (2012) Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 83:405–410. https://doi.org/10.1136/jnnp-2011-300875CrossRefPubMed

17.

Di Stefano F, Kas A, Habert M-O et al (2016) The phenotypical core of Alzheimer’s disease-related and nonrelated variants of the corticobasal syndrome: a systematic clinical, neuropsychological, imaging, and biomarker study. Alzheimer’s Dement 12:786–795. https://doi.org/10.1016/j.jalz.2016.02.005CrossRef

18.

Respondek G, Stamelou M, Kurz C et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758–1766. https://doi.org/10.1002/mds.26054CrossRefPubMed

19.

Murray R, Neumann M, Forman MS et al (2007) Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 68:1274–1283. https://doi.org/10.1212/01.wnl.0000259519.78480.c3CrossRefPubMed

20.

Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503. https://doi.org/10.1212/WNL.0b013e31827f0fd1CrossRefPubMedPubMedCentral

21.

Mesulam M-M, Weintraub S, Rogalski EJ et al (2014) Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia. Brain 137:1176–1192. https://doi.org/10.1093/brain/awu024CrossRefPubMedPubMedCentral

22.

Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279. https://doi.org/10.1016/S1474-4422(09)70042-0CrossRefPubMed

23.

De Silva R, Lashley T, Gibb G et al (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29:288–302. https://doi.org/10.1046/j.1365-2990.2003.00463.xCrossRefPubMed

24.

Kaat LD, Chiu WZ, Boon AJW, van Swieten JC (2011) Recent advances in progressive supranuclear palsy: a review. Curr Alzheimer Res 8:295–302. https://doi.org/10.2174/156720511795563809CrossRefPubMed

25.

Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9. https://doi.org/10.1212/WNL.47.1.1CrossRefPubMed

26.

Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54:S15–S19. https://doi.org/10.1002/ana.10570CrossRefPubMed

27.

Riley DE, Lang AE (1988) Corticobasal ganglionic degeneration (CBGD): further observations in six additional cases (abstract). Neurology 38:360CrossRef

28.

Lee SE, Rabinovici GD, Mayo MC et al (2011) Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70:327–340. https://doi.org/10.1002/ana.22424CrossRefPubMedPubMedCentral

29.

Ling H, O’Sullivan SS, Holton JL et al (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133:2045–2057. https://doi.org/10.1093/brain/awq123CrossRefPubMed

30.

Boeve BF (2011) The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci 45:350–353. https://doi.org/10.1007/s12031-011-9624-1CrossRefPubMed

31.

Alexander SK, Rittman T, Xuereb JH et al (2014) Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 85:923–927. https://doi.org/10.1136/jnnp-2013-307035CrossRef

32.

Whitwell JL, Jack CR, Boeve BF et al (2010) Imaging correlates of pathology in corticobasal syndrome. Neurology 75:1879–1887. https://doi.org/10.1212/WNL.0b013e3181feb2e8CrossRefPubMedPubMedCentral

33.

Josephs KA, Whitwell JL, Boeve BF et al (2010) Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer’s disease. Mov Disord 25:1246–1252. https://doi.org/10.1002/mds.23062CrossRefPubMedPubMedCentral

34.

Graham NL, Bak TH, Hodges JR (2003) Corticobasal degeneration as a cognitive disorder. Mov Disord 18:1224–1232. https://doi.org/10.1002/mds.10536CrossRefPubMed

35.

Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6CrossRefPubMedPubMedCentral

36.

Podoll K, Schwarz M, Noth J (1991) Language functions in progressive supranuclear palsy. Brain 114:1457–1472. https://doi.org/10.1093/brain/114.3.1457CrossRefPubMed

37.

Kluin KJ, Foster NL, Berent S, Gilman S (1993) Perceptual analysis of speech disorders in progressive supranuclear palsy. Neurology 43:563–566. https://doi.org/10.1212/WNL.43.3_Part_1.563CrossRefPubMed

38.

Rusz J, Bonnet C, Klempíř J et al (2015) Speech disorders reflect differing pathophysiology in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy. J Neurol 262:992–1001. https://doi.org/10.1007/s00415-015-7671-1CrossRefPubMed

39.

Kluin KJ, Gilman S, Foster NL et al (2001) Neuropathological correlates of dysarthria in progressive supranuclear palsy. Arch Neurol 58:265–269. https://doi.org/10.1001/archneur.58.2.265CrossRefPubMed

40.

Skodda S, Visser W, Schlegel U (2011) Acoustical analysis of speech in progressive supranuclear palsy. J Voice 25:725–731. https://doi.org/10.1016/j.jvoice.2010.01.002CrossRefPubMed

41.

Sachin S, Shukla G, Goyal V et al (2008) Clinical speech impairment in Parkinson’s disease, progressive supranuclear palsy, and multiple system atrophy. Neurol India 56:122–126. https://doi.org/10.4103/0028-3886.41987CrossRefPubMed

42.

Factor SA, Higgins DS, Qian J (2006) Primary progressive freezing gait: a syndrome with many causes. Neurology 66:411–414. https://doi.org/10.1212/01.wnl.0000196469.52995.abCrossRefPubMed

43.

Williams DR, Holton JL, Strand K et al (2007) Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22:2235–2241. https://doi.org/10.1002/mds.21698CrossRefPubMed

44.

Sakai K, Furui E, Komai K et al (2002) Acquired stuttering as an early symptom in a patient with progressive supranuclear palsy. Rinsho Shinkeigaku 42:178–180PubMed

45.

Della Sala S, Spinnler H (1998) Echolalia in a case of progressive supranuclear palsy. Neurocase 4:155–165. https://doi.org/10.1093/neucas/4.2.155CrossRef

46.

Testa D, Monza D, Ferrarini M et al (2001) Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci 22:247–251. https://doi.org/10.1007/s100720100005CrossRefPubMed

47.

Miller N, Nath U, Noble E, Burn D (2017) Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson’s disease, PSP and MSA-P. Neurodegener Dis Manag 7:191–203. https://doi.org/10.2217/nmt-2017-0005CrossRefPubMed

48.

Özsancak C, Auzou P, Hannequin D (2000) Dysarthria and orofacial apraxia in corticobasal degeneration. Mov Disord 15:905–910. https://doi.org/10.1002/1531-8257(200009)15:5%3c905:AID-MDS1022%3e3.0.CO;2-DCrossRefPubMed

49.

Ozsancak C, Auzou P, Jan M et al (2006) The place of perceptual analysis of dysarthria in the differential diagnosis of corticobasal degeneration and Parkinson’s disease. J Neurol 253:92–97. https://doi.org/10.1007/s00415-005-0932-7CrossRefPubMed

50.

Kompoliti K, Goetz CG, Boeve BF et al (1998) Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 55:957–961. https://doi.org/10.1001/archneur.55.7.957CrossRefPubMed

51.

Huang N, Hornberger M, Hodges JR, Burrell JR (2014) Measuring disease progression in corticobasal syndrome. J Neurol 261:1598–1605. https://doi.org/10.1007/s00415-014-7389-5CrossRefPubMed

52.

Shelley BP, Hodges JR, Kipps CM et al (2009) Is the pathology of corticobasal syndrome predictable in life? Mov Disord 24:1593–1599. https://doi.org/10.1002/mds.22558CrossRefPubMed

53.

Burrell JR, Hornberger M, Villemagne VL et al (2013) Clinical profile of PiB-positive corticobasal syndrome. PLoS ONE. https://doi.org/10.1371/journal.pone.0061025CrossRefPubMedPubMedCentral

54.

Rinne JO, Lee MS, Thompson PD, Marsden CD (1994) Corticobasal degeneration: a clinical study of 36 cases. Brain 117:1183–1196. https://doi.org/10.1093/brain/117.5.1183CrossRefPubMed

55.

Frattali CM, Grafman J, Patronas N et al (2000) Language disturbances in corticobasal degeneration. Neurology 54:990–992. https://doi.org/10.1212/WNL.54.4.990CrossRefPubMed

56.

Kertesz A, Martinez-Lage P, Davidson W, Munoz DG (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55:1368–1375. https://doi.org/10.1212/wnl.55.9.1368CrossRefPubMed

57.

Burrell JR, Ballard KJ, Halliday GM, Hodges JR (2018) Aphasia in progressive supranuclear palsy: as severe as progressive non-fluent aphasia. J Alzheimer’s Dis 61:705–715. https://doi.org/10.3233/JAD-170743CrossRef

58.

Kim J-H, McCann CM (2015) Communication impairments in people with progressive supranuclear palsy: a tutorial. J Commun Disord 56:76–87. https://doi.org/10.1016/j.jcomdis.2015.06.002CrossRefPubMed

59.

Catricalà E, Boschi V, Cuoco S et al (2019) The language profile of progressive supranuclear palsy. Cortex. https://doi.org/10.1016/j.cortex.2019.02.013CrossRefPubMed

60.

Krishnan S, Mathuranath PS, Sarma S, Kishore A (2006) Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson’s disease. Neurol India 54:268–272. https://doi.org/10.4103/0028-3886.27150CrossRefPubMed

61.

O’Keeffe FM, Murray B, Coen RF et al (2007) Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy. Brain 130:753–764. https://doi.org/10.1093/brain/awl367CrossRefPubMed

62.

Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382–2393. https://doi.org/10.1093/brain/awq158CrossRefPubMed

63.

Pillon B, Dubois B, Ploska A, Agid Y (1991) Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy. Neurology 41:634–643. https://doi.org/10.1212/WNL.41.5.634CrossRefPubMed

64.

Rosser A, Hodges JR (1994) Initial letter and semantic category fluency in Alzheimer’s disease, Huntington’s disease, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 57:1389–1394. https://doi.org/10.1136/jnnp.57.11.1389CrossRefPubMedPubMedCentral

65.

Soliveri P, Monza D, Paridi D et al (2000) Neuropsychological follow up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 69:313–318. https://doi.org/10.1136/jnnp.69.3.313CrossRefPubMedPubMedCentral

66.

Kaat LD, Boon AJW, Kamphorst W et al (2007) Frontal presentation in progressive supranuclear palsy. Neurology 69:723–729. https://doi.org/10.1212/01.wnl.0000267643.24870.26CrossRef

67.

Grafman J, Litvan I, Gomez C, Chase TN (1990) Frontal lobe function in progressive supranuclear palsy. Arch Neurol 47:553–558CrossRef

68.

Litvan I, Grafman J, Gomez C, Chase TN (1989) Memory impairment in patients with progressive supranuclear palsy. Arch Neurol 46:765–767. https://doi.org/10.1001/archneur.1989.00520430059018CrossRefPubMed

69.

Scherling CS, Hall T, Berisha F et al (2014) Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol 75:116–126. https://doi.org/10.1002/ana.24052CrossRefPubMedPubMedCentral

70.

Pillon B, Gouider-Khouja N, Deweer B et al (1995) Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson’s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 58:174–179. https://doi.org/10.1136/jnnp.58.2.174CrossRefPubMedPubMedCentral

71.

Maher ER, Smith EM, Lees AJ (1985) Cognitive deficits in the Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 48:1234–1239. https://doi.org/10.1136/jnnp.48.12.1234CrossRefPubMedPubMedCentral

72.

Soliveri P, Piacentini S, Girotti F (2005) Limb apraxia and cognitive impairment in progressive supranuclear palsy. Neurocase 11:263–267. https://doi.org/10.1080/13554790590962988CrossRefPubMed

73.

Dubois B, Pillon B, Legault F et al (1988) Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson’s disease. Arch Neurol 45:1194–1199. https://doi.org/10.1001/archneur.1988.00520350032011CrossRefPubMed

74.

Lange KW, Tucha O, Alders GL et al (2003) Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm 110:983–995. https://doi.org/10.1007/s00702-003-0011-0CrossRefPubMed

75.

Schofield EC, Hodges JR, Bak TH et al (2012) The relationship between clinical and pathological variables in Richardson’s syndrome. J Neurol 259:482–490. https://doi.org/10.1007/s00415-011-6205-8CrossRefPubMed

76.

VanVoorst WA, Greenaway MC, Boeve BF et al (2008) Neuropsychological findings in clinically atypical autopsy confirmed corticobasal degeneration and progressive supranuclear palsy. Park Relat Disord 14:376–378CrossRef

77.

Santangelo G, Cuoco S, Pellecchia MT et al (2018) Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. J Neurol 265:2602–2613. https://doi.org/10.1007/s00415-018-9038-xCrossRefPubMed

78.

Esmonde T, Giles E, Gibson M, Hodges JR (1996) Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. J Neurol 243:638–643CrossRef

79.

Grogan A, Green DW, Ali N et al (2009) Structural correlates of semantic and phonemic fluency ability in first and second languages. Cereb Cortex 19:2690–2698. https://doi.org/10.1093/cercor/bhp023CrossRefPubMedPubMedCentral

80.

Mummery CJ, Patterson K, Hodges JR, Wise RJS (1996) Generating “tiger” as an animal name or a word beginning with T: differences in brain activation. Proc R Soc B Biol Sci 263:989–995. https://doi.org/10.1098/rspb.1996.0146CrossRef

81.

Rittman T, Ghosh BC, McColgan P et al (2013) The Addenbrooke’s cognitive examination for the differential diagnosis and longitudinal assessment of patients with Parkinsonian disorders. J Neurol Neurosurg Psychiatry 84:544–551. https://doi.org/10.1136/jnnp-2012-303618CrossRefPubMedPubMedCentral

82.

Rofes A, de Aguiar V, Ficek B et al (2019) The role of word properties in performance on fluency tasks in people with primary progressive aphasia. J Alzheimer’s Dis. https://doi.org/10.3233/JAD-180990CrossRef

83.

Whiteside DM, Kealey T, Semla M et al (2016) Verbal fluency: language or executive function measure? Appl Neuropsychol Adult 23:29–34. https://doi.org/10.1080/23279095.2015.1004574CrossRefPubMed

84.

Luo L, Luk G, Bialystok E (2010) Effect of language proficiency and executive control on verbal fluency performance in bilinguals. Cognition 114:29–41. https://doi.org/10.1016/j.cognition.2009.08.014CrossRefPubMed

85.

Gerstenecker A, Mast B, Duff K et al (2013) Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol 28:104–113. https://doi.org/10.1093/arclin/acs098CrossRefPubMed

86.

Sitek EJ, Konkel A, Dąbrowska M, Sławek J (2015) Utility of frontal assessment battery in detection of neuropsychological dysfunction in richardson variant of progressive supranuclear palsy. Neurol Neurochir Pol 49:36–40. https://doi.org/10.1016/j.pjnns.2014.12.002CrossRefPubMed

87.

Pirtošek Z, Jahanshahi M, Barrett G, Lees AJ (2001) Attention and cognition in bradykinetic-rigid syndromes: an event-related potential study. Ann Neurol 50:567–573. https://doi.org/10.1002/ana.1221CrossRefPubMed

88.

Robinson GA, Spooner D, Harrison WJ (2015) Frontal dynamic aphasia in progressive supranuclear palsy: distinguishing between generation and fluent sequencing of novel thoughts. Neuropsychologia 77:62–75. https://doi.org/10.1016/j.neuropsychologia.2015.08.001CrossRefPubMed

89.

Stuss DT, Alexander MP, Hamer L et al (1998) The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc 4:265–278CrossRef

90.

Frith CD, Friston KJ, Liddle PF, Frackowiak RSJ (1991) A PET study of word finding. Neuropsychologia 29:1137–1148. https://doi.org/10.1016/0028-3932(91)90029-8CrossRefPubMed

91.

Millar D, Griffiths P, Zermansky AJ, Burn DJ (2006) Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy. Mov Disord 21:199–207. https://doi.org/10.1002/mds.20707CrossRefPubMed

92.

Abrahams S, Goldstein LH, Simmons A et al (2003) Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp 20:29–40. https://doi.org/10.1002/hbm.10126CrossRefPubMedPubMedCentral

93.

Heim S, Eickhoff SB, Amunts K (2009) Different roles of cytoarchitectonic BA 44 and BA 45 in phonological and semantic verbal fluency as revealed by dynamic causal modelling. Neuroimage 48:616–624. https://doi.org/10.1016/j.neuroimage.2009.06.044CrossRefPubMedPubMedCentral

94.

Frasson E, Moretto G, Beltramello A et al (1998) Neuropsychological and neuroimaging correlates in corticobasal degeneration. Ital J Neurol Sci 19:321–328. https://doi.org/10.1007/BF00713860CrossRefPubMed

95.

van der Hurk PR, Hodges JR (1995) Episodic and semantic memory in Alzheimer’s disease and progressive supranuclear palsy: a comparative study. J Clin Exp Neuropsychol 17:459–471. https://doi.org/10.1080/01688639508405137CrossRefPubMed

96.

Cordato NJ, Halliday GM, Caine D, Morris JG (2006) Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson’s disease. Mov Disord 21:632–638. https://doi.org/10.1002/mds.20779CrossRefPubMed

97.

Pillon B, Dubois B, Lhermitte F, Agid Y (1986) Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson’s disease, and Alzheimer’s disease. Neurology 36:1179–1185CrossRef

98.

McKenna P, Warrington EK (1983) Graded naming test. Nelson Publishing Co Ltd, Windsor

99.

Kobylecki C, Jones M, Thompson JC et al (2015) Cognitive–behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. J Neurol 262:916–922. https://doi.org/10.1007/s00415-015-7657-zCrossRefPubMed

100.

Esmonde T, Giles E, Xuereb J, Hodges J (1996) Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry 60:403–410. https://doi.org/10.1136/jnnp.60.4.403CrossRefPubMedPubMedCentral

101.

Graham NL, Bak T, Patterson K, Hodges JR (2003) Language function and dysfunction in corticobasal degeneration. Neurology 61:493–499. https://doi.org/10.1212/01.WNL.0000081230.09863.EDCrossRefPubMed

102.

Grossman M, McMillan C, Moore P et al (2004) What’s in a name: Voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain 127:628–649. https://doi.org/10.1093/brain/awh075CrossRefPubMed

103.

Massman PJ, Kreiter KT, Jankovic J, Doody RS (1996) Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer’s disease. Neurology 46:720–726. https://doi.org/10.1212/WNL.46.3.720CrossRefPubMed

104.

Cotelli M, Borroni B, Manenti R et al (2006) Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. Neuropsychology 20:558–565. https://doi.org/10.1037/0894-4105.20.5.558CrossRefPubMed

105.

Chow ML, Brambati SM, Gorno-Tempini ML et al (2010) Sound naming in neurodegenerative disease. Brain Cogn 72:423–429. https://doi.org/10.1016/j.bandc.2009.12.003CrossRefPubMedPubMedCentral

106.

Bak TH, Yancopoulou D, Nestor PJ et al (2006) Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing. Brain 129:321–332. https://doi.org/10.1093/brain/awh701CrossRefPubMed

107.

Pulvermuller F (2005) Brain mechanisms linking language and action. Nat Rev Neurosci 6:576–582. https://doi.org/10.1038/nrn1706CrossRefPubMed

108.

Robinson G, Shallice T, Cipolotti L (2006) Dynamic aphasia in progressive supranuclear palsy: a deficit in generating a fluent sequence of novel thought. Neuropsychologia 44:1344–1360. https://doi.org/10.1016/j.neuropsychologia.2006.01.002CrossRefPubMed

109.

Bak TH, Hodges JR (1998) The neuropsychology of progressive supranuclear palsy. Neurocase 4:89–94. https://doi.org/10.1093/neucas/4.2.89CrossRef

110.

Lebrun Y, Devreux F, Rousseau J-J (1986) Language and speech in a patient with a clinical diagnosis of progressive supranuclear palsy. Brain Lang 27:247–256. https://doi.org/10.1016/0093-934X(86)90019-2CrossRefPubMed

111.

Daniele A, Giustolisi L, Silveri MC et al (1994) Evidence for a possible neuroanatomical basis for lexical processing of nouns and verbs. Neuropsychologia 32:1325–1341. https://doi.org/10.1016/0028-3932(94)00066-2CrossRefPubMed

112.

Daniele A, Barbier A, Di Giuda D et al (2013) Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy. Cortex 49:948–960. https://doi.org/10.1016/j.cortex.2012.03.024CrossRefPubMed

113.

Santos-Santos MA, Mandelli ML, Binney RJ et al (2016) Features of patients with nonfluent/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol 73:733–742. https://doi.org/10.1001/jamaneurol.2016.0412CrossRefPubMedPubMedCentral

114.

Cotelli M, Borroni B, Manenti R et al (2007) Universal grammar in the frontotemporal dementia spectrum. Evidence of a selective disorder in the corticobasal degeneration syndrome. Neuropsychologia 45:3015–3023. https://doi.org/10.1016/j.neuropsychologia.2007.05.012CrossRefPubMed

115.

Spatt J, Bak T, Bozeat S et al (2002) Apraxia, mechanical problem solving and semantic knowledge: contributions to object usage in corticobasal degeneration. J Neurol 249:601–608. https://doi.org/10.1007/s004150200070CrossRefPubMed

116.

Josephs KA, Boeve B, Duffy J et al (2005) Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 11:283–296. https://doi.org/10.1080/13554790590963004CrossRefPubMed

117.

Rohrer JD, Paviour D, Bronstein AM et al (2010) Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord 25:179–188. https://doi.org/10.1002/mds.22946CrossRefPubMedPubMedCentral

118.

Sitek EJ, Barczak A, Kluj-Kozłowska K et al (2015) Writing in richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia. Neurol Neurochir Pol 49:217–222. https://doi.org/10.1016/j.pjnns.2015.05.004CrossRefPubMed

119.

Ling H, Massey LA, Lees AJ et al (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135:1141–1153. https://doi.org/10.1093/brain/aws038CrossRefPubMedPubMedCentral

120.

Gorno-Tempini ML, Murray RC, Rankin KP et al (2004) Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase 10:426–436. https://doi.org/10.1080/13554790490894011CrossRefPubMedPubMedCentral

121.

Beatty WW, Scott JG, Wilson DA et al (1995) Memory deficits in a demented patient with probable corticobasal degeneration. J Geriatr Psychiatry Neurol 8:132–136. https://doi.org/10.1177/089198879500800212CrossRefPubMed

122.

Graham NL, Zeman A, Young AW et al (1999) Dyspraxia in a patient with corticobasal degeneration: the role of visual and tactile inputs to action. J Neurol Neurosurg Psychiatry 67:334–344. https://doi.org/10.1136/jnnp.67.3.334CrossRefPubMedPubMedCentral

123.

Dubois B, Pillon B (2005) Added value of the neuropsychological evaluation for diagnosis and research of atypical parkinsonian disorders. In: Litvan I (ed) Atypical Parkinsonian disorders: clinical and research aspects. Humana Press, Totowa, pp 185–195CrossRef

124.

Grafman J, Litvan I, Stark M (1995) Neuropsychological features of progressive supranuclear palsy. Brain Cogn 28:311–320CrossRef

125.

Robbins TW, James M, Owen AM et al (1994) Cognitive deficits in progressive supranuclear palsy, Parkinson’s disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 57:79–88. https://doi.org/10.1136/jnnp.57.1.79CrossRefPubMedPubMedCentral

126.

Magherini A, Litvan I (2005) Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski’s description of PSP 40 years ago and Albert’s delineation of the subcortical dementia 30 years ago. Neurocase 11:250–262. https://doi.org/10.1080/13554790590962979CrossRefPubMed

127.

Tree JJ, Kay J (2008) Longitudinal assessment of language and memory impairments in pathologically confirmed cortico-basal ganglionic degeneration. Cortex 44:1234–1247. https://doi.org/10.1016/j.cortex.2007.08.017CrossRefPubMed

128.

Josephs KA, Duffy JR (2008) Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 21:688–692. https://doi.org/10.1097/WCO.0b013e3283168dddCrossRefPubMed

129.

McMonagle P, Blair M, Kertesz A (2006) Corticobasal degeneration and progressive aphasia. Neurology 67:1444–1451. https://doi.org/10.1212/01.wnl.0000240215.43492.01CrossRefPubMed

130.

Duffy JR (2005) Motor speech disorders: substrates, differential diagnosis, and management, 2nd edn. Elsevier, St Louis

131.

Josephs KA, Duffy JR, Strand EA et al (2012) Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 135:1522–1536. https://doi.org/10.1093/brain/aws032CrossRefPubMedPubMedCentral

132.

Boeve B, Dickson D, Duffy J et al (2003) Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 49:72–78. https://doi.org/10.1159/000068502CrossRefPubMed

133.

Mochizuki A, Ueda Y, Komatsuzaki Y et al (2003) Progressive supranuclear palsy presenting with primary progressive aphasia—clinicopathological report of an autopsy case. Acta Neuropathol 105:610–614. https://doi.org/10.1007/s00401-003-0682-5CrossRefPubMed

134.

Kertesz A, McMonagle P, Blair M et al (2005) The evolution and pathology of frontotemporal dementia. Brain 128:1996–2005. https://doi.org/10.1093/brain/awh598CrossRefPubMed

135.

Takao M, Tsuchiya K, Mimura M et al (2006) Corticobasal degeneration as cause of progressive non-fluent aphasia: clinical, radiological and pathological study of an autopsy case. Neuropathology 26:569–578. https://doi.org/10.1111/j.1440-1789.2006.00731.xCrossRefPubMed

136.

Josephs KA, Duffy JR, Strand EA et al (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385–1398. https://doi.org/10.1093/brain/awl078CrossRefPubMedPubMedCentral

137.

Ali F, Martin PR, Botha H et al (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord. https://doi.org/10.1002/mds.27619CrossRefPubMedPubMedCentral

138.

Altmann LJP, Troche MS (2011) High-level language production in Parkinson’s disease: a review. Parkinsons Dis 2011:1–12. https://doi.org/10.4061/2011/238956CrossRef

139.

Miller N (2017) Communication changes in Parkinson’s disease. Pract Neurol 17:266–274CrossRef

140.

Foley JA, Niven EH, Paget A et al (2018) Sensitivity and specificity of the ECAS in Parkinson’s disease and progressive supranuclear palsy. Parkinsons Dis. https://doi.org/10.1155/2018/2426012CrossRefPubMedPubMedCentral

141.

Taler V, Phillips NA (2008) Language performance in Alzheimer’s disease and mild cognitive impairment: a comparative review. J Clin Exp Neuropsychol 30:501–556CrossRef

142.

Hu WT, Rippon GW, Boeve BF et al (2009) Alzheimer’s disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 24:1375–1379. https://doi.org/10.1002/mds.22574CrossRefPubMed

143.

Fiorenzato E, Weis L, Falup-Pecurariu C et al (2016) Montreal cognitive assessment (MoCA) and mini-mental state examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. J Neural Transm 123:1435–1442. https://doi.org/10.1007/s00702-016-1589-3CrossRefPubMed

144.

Kertesz A (2006) Western aphasia battery-revised (WAB-R). Pro-Ed. Pearson, San Antonio

145.

Goodglass H, Kaplan E, Barresi B (2001) Boston diagnostic aphasia examination third edition (BDAE-3). Lippincott Williams & Wilkins, Philadelphia

146.

Weintraub S, Mesulam M-M, Wieneke C et al (2009) The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen 24:408–416. https://doi.org/10.1177/1533317509343104CrossRefPubMedPubMedCentral

147.

Savage S, Hsieh S, Leslie F et al (2013) Distinguishing subtypes in primary progressive aphasia: application of the sydney language battery. Dement Geriatr Cogn Disord 35:208–218. https://doi.org/10.1159/000346389CrossRefPubMed

148.

Battista P, Miozzo A, Piccininni M et al (2017) Primary progressive aphasia: a review of neuropsychological tests for the assessment of speech and language disorders. Aphasiology 31:1359–1378. https://doi.org/10.1080/02687038.2017.1378799CrossRef

149.

Schofield EC, Hodges JR, Macdonald V et al (2011) Cortical atrophy differentiates Richardson’s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 26:256–263. https://doi.org/10.1002/mds.23295CrossRefPubMed

150.

Agosta F, Kostić VS, Galantucci S et al (2010) The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32:640–647. https://doi.org/10.1111/j.1460-9568.2010.07304.xCrossRefPubMed

151.

Picillo M, Cuoco S, Tepedino MF et al (2019) Motor, cognitive and behavioral diferences in MDS PSP phenotypes. J Neurol. https://doi.org/10.1007/s00415-019-09324-xCrossRefPubMed

152.

Lopez G, Bayulkem K, Hallett M (2016) Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. Acta Neurol Scand 134:242–249. https://doi.org/10.1111/ane.12546CrossRefPubMedPubMedCentral

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Language impairment in progressive supranuclear palsy and corticobasal syndrome

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2021

Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study

Quantitative assessment of brachial plexus MRI for the diagnosis of chronic inflammatory neuropathies

Better quality of life and less caregiver strain in young-onset Parkinson’s disease: a multicentre retrospective cohort study

Hearing loss and cognitive decline in the general population: a prospective cohort study

Five men with arresting and relapsing cerebral adrenoleukodystrophy

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients